Lynda C Doward
Overview
Explore the profile of Lynda C Doward including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doward L, Balp M, Twiss J, Slota C, Cryer D, Brass C, et al.
Patient
. 2020 Dec;
14(5):533-543.
PMID: 33336323
Background: Non-alcoholic steatohepatitis (NASH) is a progressive form of non-alcoholic fatty liver disease characterized by excessive liver fat accumulation, inflammation, cell injury, and fibrosis. It is viewed as largely asymptomatic...
2.
McKenna S, Meads D, Doward L, Twiss J, Pokrzywinski R, Revicki D, et al.
Qual Life Res
. 2011 Feb;
20(7):1043-52.
PMID: 21312065
Purpose: Available patient-reported outcome (PRO) measures for chronic obstructive pulmonary disease (COPD) focus primarily on impairment (symptoms) and activities (functioning). The purpose of the study was to develop a patient-based...
3.
Twiss J, Doward L, McKenna S, Eckert B
Health Qual Life Outcomes
. 2010 Oct;
8:117.
PMID: 20937112
Background: The PRIMUS is a Multiple Sclerosis (MS)-specific suite of outcome measures including assessments of QoL (PRIMUS QoL, scored 0-22) and activity limitations (PRIMUS Activities, scored 0-30). The U-FIS is...
4.
Doward L, Gnanasakthy A, Baker M
Health Qual Life Outcomes
. 2010 Aug;
8:89.
PMID: 20727176
The use of patient reported outcome scales in clinical trials conducted by the pharmaceutical industry has become more widespread in recent years. The use of such outcomes is particularly common...
5.
McKenna S, Doward L, Twiss J, Hagell P, Oprandi N, Fisk J, et al.
Value Health
. 2010 Jul;
13(8):946-51.
PMID: 20667058
Background: The Patient-Reported Indices for Multiple Sclerosis (PRIMUS) comprises a suite of three scales for assessing symptoms, activity limitations, and quality of life in multiple sclerosis (MS). It was developed...
6.
Doward L, Meads D, Fisk J, Twiss J, Hagell P, Oprandi N, et al.
Value Health
. 2010 Mar;
13(4):463-8.
PMID: 20230543
Objective: The 22-item Unidimensional Fatigue Impact Scale (U-FIS) provides an index of the impact of fatigue on patients with multiple sclerosis (MS). The objective is to produce eight new language...
7.
Meads D, McKenna S, Doward L, Pokrzywinski R, Revicki D, Hunter C, et al.
Respir Med
. 2010 Jan;
104(5):633-43.
PMID: 20053543
Background: Current asthma patient-reported outcome (PRO) measures focus on symptoms and functioning and may not capture the holistic impact of asthma on the quality of life of the patient. Objective:...
8.
Revicki D, Rentz A, Luo M, Wong R, Doward L, McKenna S
Health Qual Life Outcomes
. 2009 Feb;
7:6.
PMID: 19183482
No abstract available.
9.
Doward L, McKenna S, Meads D, Kahler K, Frech F
Value Health
. 2008 Jul;
12(1):139-45.
PMID: 18647252
Objective: To develop measures of the day-to-day symptomatic and functional impact of recurrent genital herpes (RGH) outbreaks. The Herpes Outbreak Impact Questionnaire (HOIQ) and the Herpes Symptom Checklist (HSC) were...
10.
Doward L, Dietz B, Wilburn J, McKenna S, Bhor M, Rajagopalan R
AIDS Read
. 2008 Jul;
18(5):242-6, 252-6, 262-4.
PMID: 18589480
Lipoatrophy is a noteworthy adverse effect of antiretroviral therapy. A 2-part literature review was conducted to assess the impact of lipoatrophy in HIV-infected persons: the first reviewed the qualitative studies...